【CAS No.】 51-21-8

【Formula 】C9H14ClN3O5

【GMP National Medicine Permission Number】H11020223

【Drug Class】 Antineoplastic

【Formulation Use】 Cytarabine hydrochloride for injection (50mg/100mg)

【Packing Specification】1kg/Barrel

【Standard】 CP, EP,USP,BP ,ect 

【Description】:

Cytarabine Hydrochloride is the hydrochloride form of cytarabine, an antimetabolite analogue of cytidine with a modified sugar moiety (arabinose instead of ribose). Cytarabine is converted to the triphosphate form within the cell and then competes with cytidine for incorporation into DNA. Because the arabinose sugar sterically hinders the rotation of the molecule within DNA, DNA replication ceases, specifically during the S phase of the cell cycle. This agent also inhibits DNA polymerase, resulting in a decrease in DNA replication and repair.
NCI Thesaurus (NCIt)
A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)